Nirsevimab decreased the subsequent risk of respiratory syncytial virus infection and wheezing in the 2023–2024 RSV season
Kevin Sheng-Kai, Serena Yun‐Chen Tsai, Chadi M. El Saleeby, Camille N. Kotton, Jonathan M. Mansbach
Topics & Concepts
Respiratory systemMedicineVirusVirologyPediatricsInternal medicineRespiratory viral infections researchViral Infections and VectorsViral gastroenteritis research and epidemiology